GeoVax Labs (GOVX) Return on Sales [ROS] (2017 - 2026)
GeoVax Labs (GOVX) posted Return on Sales [ROS] of -2425.95% for Q2 2026, down 1790.14 percentage points from -635.81% a year earlier.
Powered by 
Analysis
GeoVax Labs (GOVX) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
For FY2025, GeoVax Labs' Return on Sales [ROS] came in at -869.34%, down 233.51 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of -714.88 percentage points (FY2020 to FY2025).
- In prior years, GeoVax Labs' Return on Sales [ROS] was -635.83% in FY2024, -17207.47% in FY2022 (-12344.76 pp) and -4862.72% in FY2021 (-4708.26 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Sales [ROS] since Q4 2022.
- On a year-over-year basis, Return on Sales [ROS] increased in two of the last four quarters, with an average year-over-year change of -299.53 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2025, with a gain of 1047.80 percentage points; the weakest was Q4 2022, with a drop of 8876.01 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | GeoVax Labs | 1.46 Mn | -12.87 Mn | - | -2,425.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,425.95% |
| Dec 31, 2025 | -869.34% |
| Sep 30, 2025 | -761.63% |
| Jun 30, 2025 | -635.81% |
| Mar 31, 2025 | -330.22% |
| Dec 31, 2024 | -965.32% |
| Sep 30, 2024 | -209.88% |
| Jun 30, 2024 | -1,683.61% |
| Dec 31, 2022 | -17,207.47% |
| Sep 30, 2022 | -9,081.50% |
| Jun 30, 2022 | -7,354.82% |
| Mar 31, 2022 | -2,978.24% |
| Dec 31, 2021 | -8,331.46% |
| Sep 30, 2021 | -6,416.06% |
| Jun 30, 2021 | -1,865.09% |
| Mar 31, 2021 | -1,416.52% |
| Dec 31, 2020 | -531.39% |
| Sep 30, 2020 | -105.02% |
| Jun 30, 2020 | -101.70% |
| Mar 31, 2020 | -83.15% |
API Access
GeoVax Labs Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "GOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();